New Delhi: Hemato oncology is a complex and rapidly evolving field, with new advancements and discoveries being made regularly. By understanding the different types of blood cancers, their symptoms, diagnosis, treatment options, and the latest advancements in the field, we can better support those affected by these conditions and work towards improving outcomes and quality of life.
Dr Mangesh P Kamath, Additional Director, Medical Oncology, Fortis Hospital, Cunningham Road, Bangalore
Hemato Oncology, a branch of medicine focused on the diagnosis, treatment, and management of blood-related cancers, has made significant strides in recent years. This field encompasses a range of conditions, including leukaemia, myeloma, lymphoma, and others, each with unique characteristics and treatment approaches.
Leukaemia: A Cancer of the Blood and Bone Marrow
Leukaemia, a cancer of the blood and bone marrow, occurs when abnormal white blood cells accumulate, leading to a range of complications. There are several types of leukaemia, including acute myeloid leukaemia (AML), chronic myeloid leukaemia (CML), acute lymphoblastic leukaemia (ALL), and chronic lymphocytic leukaemia (CLL). Symptoms may include fatigue, weight loss, recurrent infections, and bleeding or bruising easily. Treatment options for leukaemia include chemotherapy, targeted therapy, and bone marrow transplantation.
Myeloma: A Cancer of the Plasma Cells
Myeloma, also known as multiple myeloma, is a cancer of the plasma cells, which are responsible for producing antibodies. This condition leads to an overproduction of abnormal antibodies, causing a range of complications, including bone damage, anaemia, and kidney problems. Symptoms may include bone pain, fatigue, and recurring infections. Treatment options for myeloma include chemotherapy, targeted therapy, and stem cell transplantation.
Lymphoma: A Cancer of the Lymphatic System
Lymphoma, a cancer of the lymphatic system, occurs when abnormal white blood cells accumulate in the lymph nodes, spleen, or other lymphoid tissues. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Symptoms may include swollen lymph nodes, fever, fatigue, and weight loss. Treatment options for lymphoma include chemotherapy, radiation therapy, and targeted therapy.
Other Blood Cancers
In addition to leukaemia, myeloma, and lymphoma, there are several other types of blood cancers, including:
• Myeloproliferative neoplasms (MPNs): A group of conditions characterized by the overproduction of blood cells, leading to complications such as blood clots and bleeding.
• Myelodysplastic syndromes (MDS): A group of conditions characterized by the abnormal production of blood cells, leading to complications such as anaemia and infections.
• Amyloidosis: A condition characterized by the production and accumulation of abnormal proteins produced by abnormal immune cells in the blood, leading to complications such as kidney damage and heart problems.
Diagnosis and Treatment
Diagnosing blood cancers typically involves a combination of physical examinations, laboratory tests, and imaging studies. Treatment options vary depending on the specific type and stage of the condition but may include chemotherapy, targeted therapy, radiation therapy, and stem cell transplantation.
Advancements in Hemato Oncology
In recent years, there have been significant advancements in the field of hemato oncology, including:
• Targeted therapy: The development of targeted therapies, which specifically target cancer cells, reducing the harm to healthy cells.
• Immunotherapy: The use of immunotherapy, which harnesses the power of the immune system to fight cancer.
• Stem cell transplantation: The use of stem cell transplantation, which allows for the replacement of damaged bone marrow with healthy stem cells.
• CART (Chimeric Antigen Receptor T-cell) therapy: A type of immunotherapy that involves genetically modifying a patient’s own T-cells to recognize and attack cancer cells, offering a promising treatment option for certain types of blood cancers and solid tumours.
